1 The effects of UR-8225 [(1,2-dihydro-4-(1,2-dihydro-2-oxo-1-pyridyl)-2,2-dimethyl-1-oxonaphthalen-6-carbonitrile)] and levcromakalim were studied on the electrical and contractile responses induced by noradrenaline and KCI and on 86Rb+ efflux in rat aortic rings and on spontaneous mechanical activity in rat portal vein segments.
Introduction
Potassium channel openers constitute a class of vasodilator drugs with a novel mechanism of action. The vasorelaxant properties of this class of drugs have been initially attributed to the activation of ATP-sensitive potassium channels and the subsequent hyperpolarization of the smooth muscle membrane which prevents the opening of voltage-activated Ca2" channels (Quast & Cook, 1989; Hamilton & Weston, 1989; . As potent peripheral vasodilators these drugs are expected to be useful in the treatment of several cardiovascular disorders, such as hypertension, angina pectoris, peripheral arterial diseases, cerebral ischaemia and congestive heart failure (Cook, 1988; Hamilton & Weston, 1989; Weston, 1989; Escande & Cavero, 1992; Sanguinetti, 1992) .
UR-8225 is a new compound [(1,2-dihydro-4-(1,2-dihydro-2-oxo-1 -pyridyl)-2,2-dimethyl-1 -oxonaphthalen-6-carbonitrile)] that stems from a structure-activity study carried out at the Uriach Research Center (Almansa et al., 1992) . The key feature of the molecule is a naphthalenone ring replacing the conventional benzopyrane nucleus present in levcromakalim (formerly BRL 38227) and other related compounds ( Figure  1 ). In preliminary experiments, it has been found that UR-8225 exhibits potent vasodilator properties possibly related to its potassium channel opener properties . Therefore, the purpose of the present paper was: (1) to analyze the vasorelaxant effects of UR-8225 in rat isolated vascular smooth muscle, and (2) to compare its effects with those of levcromakalim. A preliminary report of ' Author for correspondence. some of the results of this study has already been published (Casis et al., 1993) .
Methods

Experimental procedure
Sprague-Dawley rats (either sex, 250-300 g) were killed by a blow on the head. The descending thoracic aorta and portal veins were rapidly dissected and placed in a physiological saline solution (PSS) of the following composition (mM): NaC1 118, KC1 4.75, NaHCO3 25, MgSO4 1.2, CaCl2 1.8, KH2PO4 1.2 and glucose 11. After excess of fat and connective tissue were removed, the aortae were cut into rings (4-5 mm in length). Aortic rings were mounted under the tension of 1 g by two parallel L-shaped stainless-steel holders inserted into the lumen and longitudinal portal vein segments (15 mm in length) were mounted vertically under the basal tension of 1 g in 20 ml organ baths containing PSS and attached to a force-displacement transducer (Grass FT07) to measure isometric contractile force as previously described (Perez-Vizcaino et al., 1991; . The tissue bath was maintained at 37C and bubbled with 95% 02:5% CO2 gas mixture. For the experiments in which Ca2'-free medium was used, Ca2+ was omitted from normal PSS and 0.03 mM EDTA was added. For most of the experiments care was taken not to damage the endothelium. In some experiments, endothelial cells were gently removed by rubbing the internal surface of the vessels with a small metal rod. (Ashcroft, 1988) 
86Rb+ efflux
The effects of UR-8225 on 86Rb+ efflux were determined as described by Tulenko & Cox (1991) . Aortic rings were equilibrated for 10 min in a PSS of the following composition (mM): NaCl 140, KCI 4.75, CaCI2 1.5, MgSO4 1.0, glucose 11 and HEPES 10 at pH 7.4 bubbled with 100% 02 at 37°C. Then rings were loaded for 3 h in PSS containing 86Rb+ (5 j.Ci ml-'). Afterwards the muscles were dipped quickly into PSS to remove excess radioactivity and then transferred through a series of vials (every 10 min for the first 30 min and every 3 min thereafter) each containing 0.8 ml of PSS for the first 51 min and PSS containing UR-8225 (10-6 M or 10-5 M) thereafter. At the end of the experiment, the radioactivity remaining in the aorta was determined by dissolving the vessel in 200 Atl of a solution containing equal parts perchloric acid (37% w/v) and H202 (30 volumes) heated for 15 min at 75°C. After cooling, 5 ml of Aquasol-2 (Dupont, Boston, MA, U.S.A.) was added. The 86Rb+ activity in the vials and that extracted from the tissues were measured by Cerenkov counting. The results were expressed in terms of efflux rate constants which reflect the permeability of the cell membrane to Rb+. Rate constants (k) during each time interval were calculated using the following equation: k = In (Al/A2)/(t2-tl), where Al and A2 represent the total tissue counts at time points tl and t2, respectively.
Drugs
The following drugs were used: UR-8225 (Laboratorios, Uriach, Barcelona), levcromakalim (SmithKline Beecham Pharmaceuticals Betchworth, U.K.), (-)-noradrenaline bitartrate and glibenclamide (Sigma Ltd. Co., London), methoxyverapamil (D600, Knoll AG, Ludwigshafen/Rhein, Germany). Glibenclamide was diluted in dimethyl sulphoxide to make a stock solution of 10-2 M. All other drugs were dissolved in distilled deionized water to prepare a 10-3 M stock solution and further dilutions were made in PSS. The final concentra-tion of solvent had no measurable effect on contractile responses or 86Rb+ efflux. Ascorbic acid (10-5 M) was added to each stock solution of noradrenaline, made up freshly each day.
Statistics
Throughout the paper values are expressed as mean ± s.e.mean and statistical analysis was performed with Student's t test. The differences between control and experimental values were considered significant when P < 0.05. Doseresponse slopes were analyzed to give the concentration of UR-8225 or levcromakalim producing a 50% inhibition of the maximal contractile response (ICo) using a linear regression analysis over the response range of 20 to 80% of the maximal inhibition. pA2-values were calculated by Schild-plot analysis (Arunlakshana & Schild, 1959 Figure 2 shows that UR-8225 and levcromakalim (10-9 M-10-M) inhibited the amplitude of these contractions in a concentrationdependent manner and at 2 x I0-M and I0-M, respectively, they suppressed the spontaneous activity. In 5 muscles, the IC50 values for and levcromakalim to inhibit the myogenic activity were 5.1 ± 1.4 x 10-8 M (n = 5) and 1.5 ± 0.7 x 10-8 M (n = 5), respectively. The ability of glibenclamide to reverse the inhibitory effects of UR-8225 and levcromakalim on the amplitude of spontaneous contractions was studied in 6 portal veins. In the presence of glibenclamide (3 x 10-7 M, 10-6 M and 3 x 10-6 M) there was a rightward shift of the curve for UR-8225 and levcromakalim (Figure 2 ).
Thus, in the presence of 3 x 10-6 M glibenclamide the ICm values for UR-8225 and levcromakalim were 1.5 ± 0.5 x 10-6 M and 3.2 ± 0.6 x 10-7 M, respectively. There were no differences in the calculated pA2 values for glibenclamide to inhibit UR-8225-and levcromakalim-induced inhibitions (6.76 ± 0.05 and 6.80 ± 0.18, respectively). The slope of the Schild plot yielded values not significantly different from unity (1.14 ± 0.07 and 1.07 + 0.22, respectively) which indicates that the inhibition was competitive. Addition of 10' M noradrenaline to portal vein segments induced a tonic contraction averaging 1312 ± 193 mg (n = 6). Cumulative addition of UR-8225 (10-7 M-1O-5 M) induced a concentrationdependent inhibition of these contractions, the IC50 value being 6.9 ± 3.3 x 10-6 M.
Figure when added cumulatively to aortic rings previously contracted with these agonists. UR-8225 and levcromakalim inhibited in a concentration-dependent manner the contractile responses induced by IO-M noradrenaline in endothelium intact rings, the ICso being 2.7 ± 0.4 x 10-6 M (n = 7) and 6.6 ± 1.3 x I0-M (n = 8), respectively. In endotheliumdenuded rings, UR-8225 also relaxed noradrenaline-induced contraction, the IC50 being 1.9 ± 1.1 x 10-6 M (n = 4, not significantly different compared to endothelium-intact rings). Pretreatment with glibenclamide (10-7 M-3 x 10-6 M) also shifted the concentration-responses to the right (not shown).
In contrast, at lo-M, both drugs inhibited the 80 mM KCIinduced contractions by only 11.7 ± 4.5% (P> 0.05, n = 6) and 20.5 ± 4.3% (P<0.05, n = 6), respectively. In another group of experiments, the muscles were firstly exposed to 80 mM KCI and when the contractile response reached a steady-state, I0-M noradrenaline was added to the bathing media. Figure 4 shows that under these conditions, UR-8225 or levcromakalim, I0-M-I0-M, only slightly inhibited these contractions: thus, at 10-M these responses were inhibited by 8.7 + 1.3% (n = 6) and 9.4 + 2.0% (n = 6), respectively. These results indicated that both agents were not only almost ineffective against 80 mM KCl-induced contractions but also that a strong depolarization inhibited the effects of both drugs on noradrenaline-induced contractions.
Effects on concentration-response curves to KCl Figure 3 , and levcromakalim also relaxed the contractions previously induced by 30 mM KCI, the IC50 values being 1.4 ± 0.2 x 10-7 M (n = 6) and 9.4 + 1.3 x 10-8 M (n = 6). The figure also shows that glibenclamide (10-7 M-3 x 10-6 M) shifted to the right these concentration-relaxation curves for UR-8225 and levcromakalim against these contractile responses. Thus, in the presence of 3 x 10-6 M glibenclamide, the IC50 values for UR-8225 and levcromakalim were 1.4 ± 0.4 x 10-5 M and 1.1 ± 0.1 x 10-5 M, respectively. There were no differences in the calculated pA2 values of glibenclamide to inhibit UR-8225-and levcromakalim-induced relaxations (7.61 ± 0.08 and 7.69 ± 0.10, respectively). The slope of the Schild plot yielded values not significantly different from unity (0.95 ± 0.06 and 0.96 ± 0.05, respectively) which indicates that the inhibition was competitive.
Addition of KCI (80 mM), noradrenaline (I0-5 M) or both, to aortic rings produced a contractile response which averaged 1756 ± 254 mg (n = 15), 2183 ± 530 mg (n = 15) and 2831 ± 342 (n = 10), respectively. Figure 4 shows the relaxant ----80 mM KCI (Hamilton & Weston, 1989) . Cumulative increases in KCI concentration (15-85 mM) to aortic rings in a Ca2"-containing PSS induced a concentration-dependent increase in developed tension. Figure 5 shows that both UR-8225 and levcromakalim (10-M-l0-M), produced a concentration-dependent inhibition of these contractile responses, but this inhibitory effect was more marked against the responses induced by low concentrations of KCI (< 30 mM) which were almost abolished, than against the contractions induced by 45 or 85 mM KCl. Thus, the greater the KCl concentration the less the effect induced by UR-8225 and levcromakalim.
Effects on noradrenaline-induced contractions in Ca2+-free solution
In another group of experiments, the effects of UR-8225 or levcromakalim were studied on the contractile responses induced by CaCl2 (2 mM) in aortic rings incubated in Ca2+-free PSS containing 0.03 mM EDTA and 10-SM methoxyverapamil. Under these conditions addition of 10-5M noradrenaline induced a phasic contraction resulting from the release of intracellular Ca2 . After 30 min, 2 mM CaCl2 was added to the bathing media resulting in a tonic contractile response which averaged 54.0 ± 6.1% of the initial noradrenaline-induced contraction in the absence of EDTA and methoxyverapamil. In some aortic rings run in parallel, UR-8225 or levcromakalim (10-7 M-1-0 M) was added 30 min before the addition of CaC12. As is shown in Table 1 , both drugs inhibited these tonic contractile responses induced by Ca2+, but levcromakalim was significantly more potent than UR-8225 (P < 0.05). Effects of UR-8225 on membrane potential
The resting membrane potential of aortic smooth muscle cells averaged -50.7 ± 0.7 mV (n = 7). Addition of 10-M UR-8225 hyperpolarized the cells by almost 16 mV (-66.0 ± 2.0 mV, n = 7). Upon washing, the cells slowly repolarized to their normal resting potential.
Effects of UR-8225 on 86Rb+ efflux
The magnitude of the hyperpolarization produced by UR-8225 strongly suggested that it could be due to an increase in K+ conductance. To study this possibility 86Rb+ was used as a substitute for 42K+. UR-8225 produced a concentrationdependent increase in the rate constant of 86Rb+ efflux from the rat aorta ( Figure 6 ). The rate of onset of the effect was also concentration-dependent.
Discussion
In the present study we have compared in isolated vascular smooth muscle of the rat the effects of UR-8225, a novel vasodilator agent, to those of levcromakalim, a drug which relaxes vascular smooth muscle by opening K+ channels (Weston, 1989; Weston et al., 1990 (Ashcroft, 1988) . All of these results indicated that, as previously suggested with levcromakalim (Weston, 1989; Weston et al., 1990 ) the vasorelaxant effects of UR-8225 could be related to its ability to activate ATP-sensitive K+ channels in vascular smooth muscle cells.
Potassium channel openers increase the permeability of the vascular smooth muscle cell to K+, resulting in membrane hyperpolarization (Cook, 1988; Weston, 1989) . In rat aortic smooth muscle cells, UR-8225 induced a hyperpolarization of up to 16mV shifting the membrane potential towards the predicted K+ equilibrium potential for the rat aorta (Hirst & Edwards, 1989) but far from the potential at which depolarization (voltage)-dependent L-type Ca2`channels are activated (-45 mV). Thus, the hyperpolarization induced by may reduce the intracellular concentration of free Ca2+ and cause vasorelaxation by preventing the opening of voltage-activated calcium channels by excitatory agonists (Chiu et al., 1988; Nelson et al., 1988) . To confirm whether the hyperpolarization produced by UR-8225 was due to an increase in membrane permeability to K+ the effects of the drug were studied on 86Rb+ efflux. UR-8225 produced a concentration-dependent increase in the rate of 86Rb+ efflux from rat aorta, which confirmed that UR-8225 hyperpolarizes the membrane potential and causes vascular relaxation in aortic smooth muscle through an increase in outward K+ conductance.
In addition, the sulphonylurea glibenclamide, a potent and selective blocker of ATP-sensitive K+ channels in vascular smooth muscle (Ashcroft, 1988; Standen et al., 1989) , competitively antagonized UR-8225-and levcromakalim-induced vasorelaxation. In fact, the pA2 values for glibenclamide to inhibit the relaxations induced by UR-8225 and levcromakalim were very similar, indicating that both drugs probably act at the same site. These results further support the contention that the population of potassium channels involved in the vasodilatation induced by UR-8225 could be the ATPsensitive K+ channels (Standen et al., 1989 : Quast & Cook, 1989 .
If the hypothesis that the vasorelaxant effect of UR-8225 is due to the opening of K+ channels leading to hyperpolarization and alteration in the magnitude of agonist-induced depolarization is correct, it should be markedly reduced under circumstances where the membrane potential is maintained constant. In fact, a major characteristic of K+ channel openers is that they inhibit the contractions induced by 10-30 mM KCI, whereas they are almost ineffective against the contractions induced by 80 mM KCI or noradrenaline plus high KCI (Lawson & Cavero, 1989; Weston et al., 1990) . At low KCI concentrations UR-8225, like other K+ channel openers, hyperpolarized the membrane potential decreasing the open state probability of L-type Ca2+ channels. In fact, cromakalim inhibited the increase in intracellular Ca2+ concentration induced by low concentrations (<30 mM) of KC1 in coronary arterial smooth muscle due to the closure of voltage-activated Ca2 +channels (Yanagisawa et al., 1990) . At high extracellular KCI concentrations the cell membrane is depolarized to a level far from the K+ equilibrium potential (approximately -20 mV in the presence of 80 mM KCI, Hamilton & Weston, 1989) . Under these conditions K+ channel openers do not hyperpolarize the smooth muscle cells and therefore, their vasorelaxant effect is negligible (Hamilton et al., 1986; Bray et al., 1987) . In addition, the finding that UR-8225 has no effect on high KCl-induced contractions suggests that it does not act as a conventional Ca2" channel blocker and excludes that its vasorelaxant effect can be related to a direct effect on contractile proteins.
The rat portal vein exhibits spontaneous myogenic activity which is due to depolarization induced by the influx of Na+ and Ca2+ and is insensitive to tetrodotoxin (Johansson & Somlyo, 1980) . Both levcromakalim and UR-8225 inhibited the frequency and the amplitude of spontaneous contractions. The ionic event terminating electrical excitation is a K+ outward current through voltage and/or Ca2'-dependent K+ channels (Johansson & Somlyo, 1980) . Therefore, the opening of potassium channels and the subsequent hyperpolarization can be responsible for the inhibitory effect of UR-8225 and levcromakalim on myogenic activity of rat portal veins (Hamilton et al., 1986) .
In rat aorta, the tonic component of-noradrenaline-induced contractions is due to the activation of Ca2l entry from the extracellular space via dihydropyridine-sensitive and insensitive pathways (Cauvin & Malik, 1984) . UR-8225 and levcromakalim inhibited the tonic contraction induced by adding Ca2" to a Ca2l-free medium containing EDTA and methoxyverapamil in the presence of noradrenaline, which suggests that both drugs inhibit the agonist-induced Ca2" entry (Cook, 1988; Bray et al., 1991) . Since this tonic contraction was generated in the presence of methoxyverapamil, it can be concluded that the inhibitory effect of UR-8225 and levcromakalim on K+ conductance does not require the entry of Ca2" through dihydropyridine-sensitive channels (Kreye & Weston, 1986) . The inhibitory effect on noradrenaline-induced tonic contractions can be explained because noradrenaline increases open state-probability of single voltage-activated Ca2" channels (Nelson et al., 1988; Pacaud et al., 1991) , whereas K+ channel openers oppose this action by hyperpolarizing the membrane potential (Hamilton et al., 1986; Bray et al., 1991) . Other possible explanations are that the hyperpolarization induced by UR-8225 and levcromakalim may inhibit the ability of depleted intracellular Ca2" stores to refill after Ca2" release has occurred and/or the synthesis of inositol 1,4,5-trisphosphate (IP3)-induced by noradrenaline. The former possibility has been previously reported with cromakalim in rabbit aorta (Chiu et al., 1988; Bray et al., 1991) and the latter with levcromakalim in rabbit mesenteric arteries (Ito et al., 1991) . In fact, in skinned skeletal muscles IP3 induced Ca2" release from the sarcoplasmic reticulum is voltage-dependent (Donaldson et al., 1988) .
In conclusion, the present results demonstrate that in rat vascular smooth muscle UR-8225 produced vasorelaxant responses qualitatively similar to those of levcromakalim. This vasorelaxant action seems to be mediated via hyperpolarization of the membrane by activation of ATP-activated K+ channels.
